Single-ascending Dose Study of Kylo-12 in Healthy Subjects
Single-ascending Dose Study of Kylo-12 in Healthy Subjects
Active, not recruiting · NCT06783881 · Registry updated 2026-03-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Single-ascending Dose Study of Kylo-12 in Healthy Subjects | Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, hypertriglyceridemia, metabolic disease | Active, not recruiting | Phase 1 | 2026-03-16 | NCT06783881 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Kylonova (Xiamen) Biopharma co., LTD. | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chengdu Xinhua Hospital | Chengdu | China | 4 |